Objectives: We evaluated the impact of aortic cross-clamping time (XCT) and cardiopulmonary bypass time (CPBT) on the immediate and late outcome after adult cardiac surgery and attempted to identify their safe time limits.
Methods: This study includes 3280 patients who underwent adult cardiac surgery of various complexities. Myocardial protection was achieved with tepid continuous antegrade/retrograde blood cardioplegia.
Results: Receiver operating characteristics (ROC) curve analysis showed that XCT (area under the curve, AUC: 0.66), CPBT (AUC: 0.73) and CPBT with unclamped aorta (AUC: 0.77) were significantly associated with 30-day postoperative mortality. XCT of increasing 30-minute intervals (Odds Ratio (OR) 1.21, 95%C.I. 1.01-1.52) and CPBT of increasing 30-minute intervals (OR 1.47, 95%C.I. 1.27-1.71) were independent predictors of 30-day mortality. The best cutoff value for XCT was 150 min (30-day death: 1.8% vs. 12.2%, adjusted OR 3.07, 95%C.I. 1.48-6.39, accuracy 91.5%) and for CPBT 240 min (30-day death: 1.9% vs. 31.5%, adjusted OR 8.78, 95%C.I. 4.64-16.61, accuracy 96.0%). These parameters were significantly associated also with postoperative morbidity, particularly with postoperative stroke.
Conclusions: XCT and CPBT are predictors of immediate postoperative morbidity and mortality. In our experience, cardiac procedures with CPBT<240 min and XCT<150 min were associated with a rather low risk of immediate postoperative adverse events independently of the complexity of surgery patient’s operative risk.
Guru V., Omura J., Alghamdi AA, Weisel R., Fremes SEIs blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation2006; 114(1 suppl): 1331-1338.
2.
Jacob S., Kallikourdis A., Sellke F., Dunning J.Is blood cardioplegia superior to crystalloid cardioplegia?Interact Cardiovasc Thorac Surg2008; 7: 491-499.
3.
Biancari F., Rimpiläinen R.Meta-analysis of randomized trials comparing the effectiveness of miniaturized versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart (in press).
4.
Khabar KS, elBarbary MA, Khouqeer F., Devol E., al-Gain S., al-Halees Z.Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/ multiple organ dysfunction syndromes. Clin Immunol Immunopathol1997; 85: 97-103.
5.
Whitten CW, Hill GE, Ivy R., Greilich PE, Lipton JMDoes the duration of cardiopulmonary bypasss and aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery?Anesth Analg1998; 86: 28-33.
6.
Kang N., Cole T., Tsang V., Elliott M., de Leval M.Risk stratification in paediatric open-heart surgery. Eur J Cardiothorac Surg2004; 26: 3-11.
7.
Salis S., Mazzanti VV, Merli G., et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth2008; 22: 814-822.
8.
Nashef SA, Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R.European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg1999; 16: 9-13.
Levey AS, Greene T., Kusek J., Beck G.A simplified equation to predict glomerular filtration rate from serum creatinine . J Am Soc Nephrol2000; 11: 155A.
11.
Paparella D. , Yau TM, Young E.Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg2002; 21: 232-244.
12.
Onorati F., De Feo M., Mastroroberto P., et al. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg2005 ; 79: 837-845.
13.
Bucerius J. , Gummert JF, Borger MA, et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg2003; 75: 472-478.
14.
Hogue CW Jr. , Murphy SF, Schechtman KB, Dávila-Román VGRisk factors for early or delayed stroke after cardiac surgery. Circulation1999; 100: 642-647.
